Australian healthcare stocks dive after CSL delays spinoff
** Australian healthcare stocks .AXHJ fall as much as 8% to their lowest level since November 2, 2023 ** Sub-index marks weakest trading session since mid-August ** CSL CSL.AX slips as much as 16.8% to A$176.01, lowest since December 2018, after delaying spinoff of its vaccine division ** Sub-index last down ~8% compared to a 0.4% drop in ASX 200 benchmark .AXJO (Reporting by Sneha Kumar in Bengaluru) ((Sneha.kumar@thomsonreuters.com))
Recent news on Csl
See all newsEU Commission opens antitrust probe into Sanofi's flu vaccine campaign (updated)
EU Commission opens antitrust probe into Sanofi's flu vaccine campaign
Analysis: US prices for new drugs fell in 2025 as fewer costly gene therapies were launched
US military requires flu vaccine for some after outbreak in Texas training center
Corrected: BUZZ-Australian healthcare stocks hit a six-week high, acting as a primary hedge on ASX